Maternal stress could leave epigenetic imprints on genes in the placenta associated with cortisol—a necessary hormone for fetal development—and this would affect the baby's development from very early stages, according ...
Jan 29, 2025
0
34
In the town that Olutosin Adesogan grew up in, disparities were on full display. On one side of Main Street, a plethora of parks, doctors' offices, grocery stores. On the other, concrete and convenience stores reigned supreme.
Jan 29, 2025
0
0
Integrated behavioral health (IBH), which combines behavioral health and primary care, improves patient outcomes and experience. A study published in The Annals of Family Medicine evaluated whether a tailored, toolkit-based ...
Jan 28, 2025
0
0
Depression impacts an estimated 18 million Americans each year, yet depression screening rarely occurs in the outpatient setting. A study appearing in The Annals of Family Medicine evaluated an AI-based machine learning biomarker ...
Jan 28, 2025
0
0
A new study from the Texas A&M University School of Public Health provides additional evidence that meditation using immersive virtual reality devices provides greater relief from depression and anxiety symptoms than meditation ...
Jan 28, 2025
0
83
Bringing a baby into the world is often portrayed as one of life's happiest moments. While this is true for many, it's also normal to feel overwhelmed during the postpartum period. Mental health conditions are the most common ...
Jan 27, 2025
0
0
Rates of post-traumatic stress disorder (PTSD) combined with anxiety disorders or diagnoses of depression increased by 177% and 138% in only five years, from 2019 to 2023, according to the Medical Surveillance Monthly Report, ...
Jan 27, 2025
0
4
Researchers at Rutgers University have found that adverse childhood experiences can make people more sensitive to potential threats from others, which in turn increases their risk of engaging in defensive gun use in adulthood.
Jan 23, 2025
0
0
Would you give up your sense of smell to keep your hair? What about your phone?
Jan 23, 2025
0
0
The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral antidepressants, according ...
Jan 22, 2025
0
1
